novo nordisk oral semaglutide oral glp-1 Nordisk's drug didn't work on Alzheimer's as hoped, but don't call it a failure FDA Approves Oral Semaglutide: First – FDA approves oral semaglutide Rybelsus

Tirzepatide (Mounjaro): A dual GIP/ GLP-1 agonist

Different mechanism, same opportunity

5-Amino-1MQ Dosage Chart | Quick Breakdown What is 5-Amino-1MQ 5-Amino-1-methylquinolinium (5-amino-1MQ) is a small molecule that is studied for its potential influences on body weight, metabolic health, and possibly cancer progression

An IM dose administered SubQ will take 23 longer to reach peak plasma levels (34 hours vs 6090 minutes) and will produce lower Cmax but sustained elevation over 68 hours instead of clearing by hour 4

A GIC official said last November that the agency determined that using a vendor to manage GLP-1 drugs for weight loss more closely was the most responsible next step to achieve savings and maintain GIC coverage for GLP-1s for weight loss. Zucchi called the new program infuriating because hes been treating patients, like state employee Deb LaValle, for several years with obesity medications